title: Perforin is a critical physiologic regulator of T-cell activation.
abstract: Individuals with impaired perforin-dependent cytotoxic function (Ctx(-)) develop a fatal inflammatory disorder called hemophagocytic lymphohistiocytosis (HLH). It has been hypothesized that immune hyperactivation during HLH is caused by heightened infection, defective apoptosis/responsiveness of Ctx(-) lymphocytes, or enhanced antigen presentation. Whereas clinical and experimental data suggest that increased T-cell activation drives HLH, potential abnormalities of T-cell activation have not been well characterized in Ctx(-) hosts. To define such abnormalities and to test these hypotheses, we assessed in vivo T-cell activation kinetics and viral loads after lymphocytic choriomeningitis virus (LCMV) infection of Ctx(-) mice. We found that increased T-cell activation occurred early during infection of Ctx(-) mice, while they had viral burdens that were identical to those of WT animals, demonstrating that T-cell hyperactivation was independent of viral load. Furthermore, cell transfer and signaling studies indicated that increased antigenic stimulation, not a cell-intrinsic defect of responsiveness, underlay heightened T-cell activation in vivo. Finally, direct measurement of viral antigen presentation demonstrated an increase in Ctx(-) mice that was proportional to abnormal T-cell activation. We conclude that perforin-dependent cytotoxicity has an immunoregulatory role that is distinguishable from its pathogen clearance function and limits T-cell activation in the physiologic context by suppressing antigen presentation.
authors: Division of Immunobiology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center and University of Cincinnati College of Medicine, Cincinnati, OH, USA.
authors: Jennifer E
authors: JE
authors: Lykens
authors: Catherine E
authors: CE
authors: Terrell
authors: Erin E
authors: EE
authors: Zoller
authors: Kimberly
authors: K
authors: Risma
authors: Michael B
authors: MB
authors: Jordan
references: Curr Opin Allergy Clin Immunol. 2006 Dec;6(6):410-5
references: 17088644
references: J Immunol. 2006 Aug 15;177(4):2518-26
references: 16888013
references: Pediatrics. 2007 Sep;120(3):e622-8
references: 17698967
references: Vaccine. 1996 Sep;14(13):1223-9
references: 8961509
references: J Immunol. 2005 May 15;174(10):5936-40
references: 15879085
references: J Virol. 2001 Oct;75(20):9918-24
references: 11559824
references: Immunity. 2003 Apr;18(4):463-74
references: 12705850
references: J Virol. 1999 Mar;73(3):2527-36
references: 9971838
references: Genes Dev. 2003 Sep 15;17(18):2205-32
references: 12975316
references: J Virol. 1998 May;72(5):4515-9
references: 9557751
references: Curr Opin Immunol. 1996 Aug;8(4):472-7
references: 8794015
references: Bone Marrow Transplant. 2008 Oct;42(7):433-7
references: 18679369
references: J Immunol. 2005 Jan 15;174(2):718-26
references: 15634891
references: Eur J Immunol. 1992 Jul;22(7):1803-12
references: 1623925
references: Immunity. 1998 Jun;8(6):675-82
references: 9655481
references: Nat Immunol. 2007 Jul;8(7):743-52
references: 17529983
references: J Virol. 2005 Jan;79(1):661-7
references: 15596864
references: Virus Res. 1999 Dec 15;65(2):97-101
references: 10581382
references: J Exp Med. 2007 Apr 16;204(4):853-63
references: 17420270
references: Immunity. 2000 May;12(5):451-7
references: 10843378
references: Pediatr Blood Cancer. 2007 Feb;48(2):124-31
references: 16937360
references: J Immunol. 2000 Mar 15;164(6):3095-101
references: 10706699
references: Science. 2000 Nov 17;290(5495):1354-8
references: 11082062
references: Eur J Immunol. 1987 Dec;17(12):1843-6
references: 2961577
references: Eur J Immunol. 1999 Oct;29(10):3262-72
references: 10540338
references: J Gen Virol. 2001 Aug;82(Pt 8):1971-1981
references: 11458005
references: Med Pediatr Oncol. 1997 Sep;29(3):157-66
references: 9212839
references: Immunity. 2006 Nov;25(5):835-48
references: 17088087
references: J Immunol Methods. 2003 Oct 1;281(1-2):65-78
references: 14580882
references: Proc Natl Acad Sci U S A. 1991 Sep 15;88(18):8252-6
references: 1910175
references: Leuk Lymphoma. 2001 Jun;42(1-2):13-20
references: 11699200
references: Science. 1999 Dec 3;286(5446):1957-9
references: 10583959
references: J Exp Med. 1998 Jun 1;187(11):1903-20
references: 9607930
references: Immunol Rev. 2005 Feb;203:165-79
references: 15661029
references: J Immunol Methods. 2006 Apr 20;311(1-2):117-29
references: 16563425
references: Proc Natl Acad Sci U S A. 2006 Jan 3;103(1):147-52
references: 16373503
references: J Exp Med. 1998 May 4;187(9):1383-93
references: 9565631
references: Hematology Am Soc Hematol Educ Program. 2005;:82-8
references: 16304363
references: J Exp Med. 1988 May 1;167(5):1749-54
references: 2966846
references: Blood. 2004 Aug 1;104(3):735-43
references: 15069016
references: Proc Natl Acad Sci U S A. 2007 Apr 10;104(15):6341-6
references: 17400753
references: Microb Pathog. 2003 Apr;34(4):161-7
references: 12668139
references: Eur J Immunol. 2008 Nov;38(11):3219-25
references: 18991284
references: Med Pediatr Oncol. 2002 May;38(5):305-9
references: 11979453
references: Immunity. 2010 Feb 26;32(2):266-78
references: 20137985
references: J Neuroimmunol. 2001 Jun 1;116(2):125-35
references: 11438167
references: Proc Natl Acad Sci U S A. 1995 Jun 6;92(12):5679-83
references: 7777569
references: J Exp Med. 2010 Jun 7;207(6):1333-43
references: 20513749
references: Nat Rev Immunol. 2005 Jun;5(6):472-84
references: 15928679
references: Emerg Infect Dis. 2000 Nov-Dec;6(6):601-8
references: 11076718